As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Bavencio is an anti PD-L1 immunotherapy which works by enabling the patient’s immune system to attack and destroy cancer cells. NICE has made its recommendation even though the drug has been ...

WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) with generous support from EMD Serono's Embracing Caregivers initiative, announced today ...